Senior Launch Manager at Bristol-Myers Squibb

Madison, New Jersey, United States

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

  • Bachelor’s degree in supply chain, engineering, life sciences, business, or a related field is required; advanced degree preferred
  • 3-5 years of project and program management experience, including leading complex matrix teams
  • Excellent organization, communication, and relationship-building skills
  • Successful track record of managing complex projects, launches and/or lifecycle transitions, preferably within Cell Therapy
  • Proficiency in project management software, OnePlan Portfolio Management and SmartLaunch a plus
  • Strong understanding of the pharmaceutical product lifecycle and operating within a regulated environment
  • Strong analytical problem solving and critical thinking skills with ability to work independently and take initiative
  • PMP certification strongly preferred

Responsibilities

  • Lead a cross-functional team to ensure manufacturing launch readiness timelines are met for multiple commercial and clinical launches
  • Develop and manage detailed project launch plans, milestones, and deliverables utilizing SmartLaunch
  • Plan, schedule, and manage effective meetings with clear agendas, pre-reads, and subsequent meeting minutes and follow up actions
  • Communicate project status, updates, and risks clearly to stakeholders and leadership
  • Identify, assess, and proactively mitigate launch risks while ensuring compliance with schedules and quality/regulatory standards
  • Open and manage the global launch change control in BMS quality system
  • Drive operational excellence and foster a collaborative environment that encourages best practices and continuous improvement
  • Facilitate change management and adoption of new launch processes or systems
  • Ensure documentation of lessons learned and capture best practices for future launches
  • Assist with onboarding and training new launch managers and providing backup coverage

Skills

Project Management
Launch Management
Cross-Functional Team Leadership
Manufacturing Readiness
Cell Therapy
Stakeholder Communication
Meeting Management
Global Project Coordination

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI